37 devices · GMDN 56092
Platelet aggregation study reagents are in vitro diagnostic (IVD) substances designed to help assess how well blood platelets clump together—a key process in preventing excessive bleeding. Clinically, these reagents are used in lab tests to evaluate platelet function, often in patients with bleeding disorders, before surgeries, or during monitoring of antiplatelet therapies like aspirin or clopidogrel.
These reagents are typically classified as IVDs and regulated under strict quality and performance standards, though classification varies by jurisdiction. They are supplied as standalone components to pair with parent assay systems, ensuring compatibility with specific platelet aggregation agents like ADP, collagen, or thrombin. Always verify regulatory compliance before use, as requirements differ by country and intended clinical application.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.